Press-release for stocks for TWST

Prices are updated after-hours

symbols : TWST

save search

Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -0.04% | O: -0.04% H: 0.0% C: 0.0%
report bioscience financial results

Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
Published: 2024-03-05 (Crawled : 15:30) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -25.31% | O: -1.15% H: 0.9% C: -2.67%
precision bioscience

Twist Bioscience to Present at Upcoming Investor Conferences - February 22, 2024
Published: 2024-02-22 (Crawled : 17:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -25.55% | O: 1.33% H: 0.89% C: -0.64%
bioscience

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - February 7, 2024
Published: 2024-02-07 (Crawled : 13:30) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -22.75% | O: -1.08% H: 1.07% C: -4.38%
nasdaq corporation bioscience grants

Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
Published: 2024-02-06 (Crawled : 14:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -21.56% | O: -0.33% H: 3.06% C: 1.87%
bioscience

Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
Published: 2024-02-06 (Crawled : 14:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -21.56% | O: -0.33% H: 3.06% C: 1.87%
bioscience system solutions

Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
Published: 2024-02-05 (Crawled : 14:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -21.95% | O: -2.98% H: 2.76% C: 2.56%
solution bioscience

Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
Published: 2024-02-02 (Crawled : 13:30) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -14.13% | O: 14.25% H: 0.11% C: -3.71%
first bioscience financial results

Twist Bioscience Expands Express Genes Rapid Synthesis Service
Published: 2024-01-24 (Crawled : 14:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -16.98% | O: 4.8% H: 0.0% C: -9.38%
service rapid express bioscience

Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Published: 2024-01-08 (Crawled : 14:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -15.95% | O: -0.44% H: 3.67% C: 3.4%
nasdaq corporation bioscience grant

Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
Published: 2024-01-05 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| -10.19% | O: -0.56% H: 0.0% C: 0.0%
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -14.9% | O: -2.12% H: 3.99% C: 3.44%
TSLA | $147.01 -1.95% -1.99% 86M

Consumer Durables

| -34.67% | O: -0.45% H: 1.38% C: 0.27%
EAR | $2.57 7.78% 200K

Health Technology

| -0.77% | O: 0.39% H: 0.0% C: 0.0%
bioscience financial

Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-18 (Crawled : 15:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| -17.48% | O: 0.61% H: 2.67% C: -0.75%
conference bioscience

Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
Published: 2023-11-17 (Crawled : 17:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 49.76% | O: 8.02% H: 20.78% C: 16.55%
year bioscience financial results

Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
Published: 2023-11-14 (Crawled : 14:30) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 65.47% | O: 10.37% H: 4.57% C: 3.25%
service rapid express bioscience

Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
Published: 2023-11-13 (Crawled : 14:30) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 69.29% | O: -2.07% H: 4.54% C: 4.48%
conference bioscience

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 56.58% | O: 0.0% H: 0.0% C: -4.61%
nasdaq corporation bioscience grants

Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
Published: 2023-11-02 (Crawled : 00:00) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 82.84% | O: 3.97% H: 7.94% C: 6.59%
report year bioscience financial results

Bayer to Partner With Twist Bioscience to Accelerate Drug Discovery
Published: 2023-10-05 (Crawled : 13:30) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 52.81% | O: 6.74% H: 0.25% C: -5.91%
drug bioscience

Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
Published: 2023-10-05 (Crawled : 13:30) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 52.81% | O: 6.74% H: 0.25% C: -5.91%
antibody bioscience agreement

Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
Published: 2023-10-03 (Crawled : 13:30) - biospace.com/
TWST | $27.92 -1.55% -1.58% 1.1M

Health Technology

| 48.98% | O: -0.99% H: 2.27% C: -3.21%
bioscience